Tessier Lavigne Marc Insider Trades

Insider Trading History

Track insider trading activity for Tessier Lavigne Marc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $356k 18,111 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$252k 18,111 shares
$13.93
$19.66
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $37.1M 1,886,576 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.1k 6,037 shares
$13.93
$19.66
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $37M 1,880,539 shares
Last Trade
May 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$332k 17,901 shares
$18.56
$19.66
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $36.9M 1,874,572 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$391k 12,649 shares
$30.92
$19.66
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.19M 1,929 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.39M 1,929 shares
$720.47
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.19M 1,929 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.39M 1,929 shares
$720.47
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.51M 2,434 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119k 165 shares
$720.47
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.51M 2,434 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119k 165 shares
$720.47
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.19M 1,929 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 1,929 shares
$725.89
$618.95
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $36.8M 1,870,356 shares
Last Trade
Nov 23, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$610k 20,000 shares
$30.48
$19.66
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $37.2M 1,890,356 shares
Last Trade
Nov 02, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$341k 11,252 shares
$30.33
$19.66
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $37.4M 1,901,608 shares
Last Trade
Nov 01, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$264k 8,748 shares
$30.20
$19.66
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $3.64M 5,881 shares
Last Trade
Oct 03, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.66M 3,612 shares
$735.13
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $0 0 shares
Last Trade
Oct 03, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.66M 3,612 shares
$735.13
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.4M 2,269 shares
Last Trade
Oct 03, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.59M 3,612 shares
$718.00
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $3.53M 5,697 shares
Last Trade
Sep 30, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.36M 3,428 shares
$688.87
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.4M 2,269 shares
Last Trade
Sep 30, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.39M 3,428 shares
$698.00
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $2.24M 3,612 shares
Last Trade
Sep 30, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.36M 3,428 shares
$688.87
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $3.55M 5,730 shares
Last Trade
Sep 29, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$221k 321 shares
$687.90
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $3.76M 6,067 shares
Last Trade
Sep 29, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.63M 3,798 shares
$691.82
$618.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up